Pharmacy Times

DEC 2015

Pharmacy Times offers relevant, clinical information for pharmacists that they can use in their daily practice. These include OTC and Rx product news, disease conditions, patient education guides, drug diversion and abuse, and more.

Issue link: http://pharmacytimes.epubxp.com/i/614520

Contents of this Issue

Navigation

Page 20 of 70

Introducing Dexcom Continuous Glucose Monitoring (CGM). Dexcom G5 ™ Mobile is the world's fi rst CGM on the phone. * NOW AT PHARMACY CGM is proven to be the best glycemic management system for reducing A1C without increasing hypoglycemia 2 Receiver is part of the G5 system; smart device sold separately. LBL013678 Rev 001 BRIEF SAFETY STATEMENT The Dexcom G5 Mobile Continuous Glucose Monitoring System is a glucose monitoring system indicated for detecting trends and tracking patterns in persons (age 2 years and older) with diabetes. CONTRAINDICATIONS: Remove the System before MRI, CT scan, or diathermy treatment. The device is MR Unsafe. Do not bring any portion of the System into the MR environment. Taking acetaminophen while wearing the sensor may falsely raise your sensor glucose readings. WARNING: Do not use the System for treatment decisions. The System does not replace a blood glucose meter. The System is not approved for use in pregnant women, persons on dialysis or critically ill persons. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have an infection or infl ammation. Report broken sensors to Dexcom Technical Support. Sensor placement is not approved for sites other than under the skin of the belly (ages 2 years and older) or upper buttocks (ages 2–17 years). Your smart device's internal settings override your app settings. Accessory devices (like a smart watch) might override your smart device's alert and notifi cation settings. The Share feature must be turned "On" with an active Internet connection to communicate glucose information to a Follower. The Follower must download and install the Dexcom Follow app onto a separate smart device with an active Internet connection to receive data. Contact Dexcom toll-free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information. ©2015 Dexcom, Inc. All rights reserved. This product is covered by U.S. patent. DEXCOM, Dexcom G5, and ONE STEP AHEAD are trademarks and registered trademarks of Dexcom, Inc. All trade dress used in connection with Dexcom products and services appearing herein are property of Dexcom and protected by the United States and foreign trademark laws. 1 Dexcom G5 Mobile CGM User Guide, 2015. 2 JDRF Continuous Glucose Monitoring Study Group. N Engl J Med. 2008;359(14):1464-1476. *For a list of compatible devices, visit www.dexcom.com/compatibility. Discover how Dexcom G5 ™ Mobile is changing diabetes management at Dexcom.com/Pharmacy1. DEXCOM G5 ™ MOBILE 1 : Lets your patients on insulin track their glucose levels, speed, and direction on their smartphones * with glucose readings every 5 minutes Has audio alerts that warn your patients of approaching glucose highs and lows Allows your patients to share their results with up to 5 followers Is available at pharmacy

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmacy Times - DEC 2015